Schedule 13G ownership disclosure
MABVAX THERAPEUTICS HLDGS INC COM
Security class unavailable · CUSIP: 55414P108
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-040835
- Form type
- SC 13G
- Filer
- BIOMARK CAPITAL FUND IV LP
- CIK
- CIK 1614166
- Filed
- Feb 10, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership